Meta Biomed to Acquire and Potentially Cancel Treasury Shares Worth KRW 3 Billion
-
Decision to acquire treasury shares worth KRW 3 billion (acquisition amount: KRW 3,000,000,000)
-
Reference price per share: KRW 4,010 (closing price on the day before board resolution)
-
Purpose: Enhance shareholder value
-
Expected acquisition period: Completion within first half (may end early)
-
Intended to be cancelled or used for employee compensation after acquisition
-
Daily purchase order limit: 74,813 shares
KOSDAQ Filing Information
-
Filing: Report on Major Matters (Decision on Acquisition of Treasury Shares)
-
Company: METABIOMED (059210)
-
Submission: METABIOMED.CO.,LTD
-
Receipt: 05-14-2026